• News & Events
  • Resources
  • Careers
  • Investors
Aptar Logo
  • Products
  • business areas
  • Services
  • ESG
  • About Aptar
Pharmaceutical, Webinars

Injectable Drug Packaging: Why Component Quality Matters

27 Oct 2026

Aptar Pharma experts discuss component quality in injectable drug packaging, the evolving needs of biologics and combination products, and what to expect from a component partner.

By Estelle Verger, Nicolas Voisin
$resourceAuthor.title, $resourceAuthor.title
Share
aptar-pharma-injectable-drug-packaging-component-quality-cphi-2026.png

When Every Component Matters: Quality in Injectable Drug Packaging

Estelle Verger and Nicolas Voisin from Aptar Pharma’s Injectables business discuss component quality, the changing needs of injectable therapies, and what to expect from a component partner.

 

How do you make component quality predictable?

As biologics and combination products become increasingly demanding, variability at the component level can introduce risks across development and manufacturing.

Watch the video to listen to Estelle Verger and Nicolas Voisin from Aptar Pharma’s Injectables business explore what it takes to achieve predictable component quality and what pharma and biotech teams should expect from their component partners.

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery

 

Find Out More About Injectable Drug Delivery

This Might Also Be of Interest

27 Oct 2026
Injectable Drug Packaging: Why Component Quality Matters

Pharmaceutical Webinars
19 Oct 2026
USP <382> System-Level Insights for Earlier Primary Packaging Decisions

Pharmaceutical Publications
29 Sep 2026
Where Does Your Contamination Control Strategy Really End?

Pharmaceutical Blogs
22 Sep 2026
The Elastomeric Stopper as Part of a System: Considerations Under USP <382>

Pharmaceutical Publications